Dergiler / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 2

Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?

Sayfa
199–203
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

C-reactive protein had a positive and significant correlation with CtH (r=0.548, p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Despite the important improvements in prevention and treatment, febrile neutropenia is still a commonchallenge in patients with certain hematological disorders.
📊
Temel Bulgular & Veri:Therefore, 168 serum samples, which were obtained from 26 patients with hematological disorders were dividedinto three groups; Febrile neutropenia, non-febrile neutropenia and control group.Results: The mean serum CRP, CtH and NGAL levels of febrile neutropenia group were significantly higher than theother two groups (p0.05).
💡
Sonuç & Katkı:C-reactive protein had a positive and significant correlation with CtH (r=0.548, p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Despite the important improvements in prevention and treatment, febrile neutropenia is still a commonchallenge in patients with certain hematological disorders. Many biomarkers have been explored to identify high-riskneutropenic patients, which need hospitalization and broad-spectrum antibiotic treatment. In the present study, firstly,we aimed to investigate serum CRP, Chitotriosidase (CtH) and Neutrophil gelatinase-associated lipocalin level (NGAL) infebrile neutropenia, non-febrile neutropenia and control groups. Secondly, to evaluate the usefulness of CRP, CtH andNGAL as a inflammatory biomarker to detect slight inflammatory change associated with infection in these patients.Methods: This was a single center prospective study that investigated ChT and NGAL as a new biomarkers to detectslight inflammatory change associated with infection in febrile neutropenia, non-febrile neutropenia and controlgroups. Therefore, 168 serum samples, which were obtained from 26 patients with hematological disorders were dividedinto three groups; Febrile neutropenia, non-febrile neutropenia and control group.Results: The mean serum CRP, CtH and NGAL levels of febrile neutropenia group were significantly higher than theother two groups (p0.05). C-reactive protein had a positive and significant correlation with CtH (r=0.548, p

🔖

Bu Makaleye Atıf Yap

KARTAL, Ö., GÜRSEL, O., EKER, İ., TAŞÇILAR, M. E., TAPAN, S., KÜREKÇİ, A. E. (2022). Chitotriosidase and Neutrophil Gelatinase-Associated Lipocalin: New Methods as a Diagnostic Marker of Infection in Patients with Febrile Neutropenia?. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 2, 199–203. https://ajindex.com/articles/508653

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2010
  2. 252–6. [CrossRef ] 2. Hazan G, Ben-Shimol S, Fruchtman Y, Abu-Quider A, Kapelushnik J, Moser A, et al. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia. J Pediatr Hematol Oncol 2014
  3. 275–9. [CrossRef ] 3. Lappalainen M, Jokkala J, Juutilainen A, Hämäläinen S, Koivula I, Jantunen E, et al. Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics. Dis Markers 2018
  4. 6964529. [CrossRef ] 4. Purkayastha K, Seth R, Amitabh S, Xess I, Kapil A and Sreenivas V. To Determine the Role of Procalcitonin in Febrile Neutropenic Episodes of Children Undergoing Treatment for Childhood Cancers. J Clin Case Reports 2016
  5. 4–8. [CrossRef ] 5. la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, et al. De-escalation and discontinuation strategies in highrisk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis 2018
  6. 1931–40. [CrossRef ] 6. Sklavou R, Karavanaki K, Critselis E, Kossiva L, Giannaki M, Tsolia M, et al. Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen. Clin Biochem 2012
  7. 1178– 82. [CrossRef ] 7. Coskun O, Ozturk M, Erdem H, Gumral R, Yaman H, Karakas A, et al. Can chitotriosidase be a surrogate marker for invasive fungal disease? J Mycol Med 2012
  8. 256–60. [CrossRef ] 8. Chiarla C, Giovannini I, Antuzzi D, Piras A, Ardito F, Giuliante F. Clinical use of plasma chitotriosidase in severe sepsis. Curr Med Res Opin 2016
  9. 273–6. [CrossRef ] 9. Di Rosa M, Malaguarnera L. Chitotriosidase: A new inflammatory marker in diabetic complications. Pathobiology 2016
  10. 211–9. [CrossRef ] 10. Roli L, Pecoraro V, Trenti T. Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence. Int J Biol Markers 2017
  11. 53–61. 11. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage. Am J Kidney Dis 2008
  12. 595–605. [CrossRef ] 12. Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, et al. Evaluation of procalcitoni